Economic Outcomes in Patients with Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate Plus Prednisone.

Adv Ther · 2020 · PMC7467473 · PMID 32112280

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

practically significantno p-value reported

In addition, standardized differences are indicative of practical/clinical significance; for this purpose, SMDs greater than 10 are indicative of practically significant differences between the treatment cohorts.

also in 1,558 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.